Genetic Variants in Host Protein Disulfide Isomerase 2 (PDIA2) are Associated with Susceptibility to Chlamydia Trachomatis Infection.


Journal

Journal of the Association of Genetic Technologists
ISSN: 1523-7834
Titre abrégé: J Assoc Genet Technol
Pays: United States
ID NLM: 9807282

Informations de publication

Date de publication:
2020
Historique:
received: 07 12 2020
accepted: 07 12 2020
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 10 12 2020
Statut: ppublish

Résumé

Objective: Host genetics can influence susceptibility to Chlamydia trachomatis infection. This study examined two genetic variants in human protein disulfide isomerase A2 (PDIA2), a member of a family of protein chaperones that participate in the chlamydial life cycle. Methods: A total of 278 male and female subjects, positive or negative for C. trachomatis infection, were genotyped for PDIA2 polymorphisms (rs400037 and rs419949) using real-time PCR and pyrosequencing. Results: There was a significant odds ratio of 8.21 (95% CI: 1.77-38.16) for rs400037 and 9.89 (95% CI: 1.19-82.10) for rs419949, for the AA genotypes. Conclusion: This indicates that individuals with the PDIA2 AA genotypes have significantly increased susceptibility to C. trachomatis infection as compared to the other PDIA2 genotypes (GG, GA). This correlation may be explained by an interactive role of host protein disulfide isomerases in the attachment and entry of C. trachomatis into cells.

Identifiants

pubmed: 33293489

Types de publication

Journal Article

Langues

eng

Pagination

244-249

Informations de copyright

Copyright© by the Association of Genetic Technologists.

Auteurs

Christopher Zysk (C)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Steven Williams (S)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Itzel Chavarria (I)

Forensic Science, College of Arts and Sciences, Texas Tech University, Lubbock, TX Funded by: The South Plains Foundation.

Hailey Wilson (H)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Adedayo Balogun (A)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Emily Jacobs (E)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Rachel Kaminski (R)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Baru-Ta Foma (BT)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Jack Johnson (J)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Wesley Lux (W)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Kristyn McCoy (K)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Stephen Morales (S)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Gina Sanchez (G)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Paul Grubb (P)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Melanie Littlejohn (M)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Ryan Mize (R)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Jorge Moreno (J)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Caryn Pirtle (C)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Ericka C Hendrix (EC)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Katie M Bennett (KM)

Molecular Pathology, Department of Laboratory Science and Primary Care, Texas Tech University Health Sciences Center, Lubbock, TX.

Classifications MeSH